Ganga Pharmaceuticals Limited (BOM:539680)
India · Delayed Price · Currency is INR 12.50
+0.50 (4.17%)
At close: Sep 8, 2026
Ganga Pharmaceuticals Market Cap
Ganga Pharmaceuticals has a market cap or net worth of 73.89 million as of November 6, 2026. It is the 49,758th most valuable company in the world and the 5,330th biggest in India. Its market cap has decreased by 14.38% in one year.
Market Cap
73.89M
Enterprise Value
84.21M
Revenue
28.21M
Global Rank
Country Rank
#5,330 India
PE Ratio
41.67
ChartMarket Cap Chart
Since February 22, 2016, Ganga Pharmaceuticals's market cap has increased from 58.89M to 73.89M, an increase of 25.47%. That is a compound annual growth rate of 2.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 73.89M | -17.95% |
| Dec 13, 2024 | 90.06M | -22.17% |
| Dec 27, 2023 | 115.71M | 213.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 146.71M |
| Desh Rakshak Aushdhalaya | 139.61M |
| Unjha Formulations | 124.92M |
| Beryl Drugs | 117.87M |
| Emmessar Biotech & Nutrition | 113.61M |
| Ortin Global | 101.81M |
| Brawn Biotech | 69.49M |
| Vivanza Biosciences | 54.40M |